RBV CAPITAL
RBV Capital is a dedicated life sciences venture fund based in Zug, Switzerland. We invest into diversified assets in pharmaceuticals, biologics, digital healthcare products and medical devices answering to an unmet medical and market need and with a potential for global outreach.
RBV CAPITAL
Industry:
Venture Capital
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Nginx Google Apps For Business Google Maps Hetzner
Similar Organizations
Credit Suisse First Boston
Credit Suisse First Boston was the investment banking division of Credit Suisse Group.
Refactor Capital
Refactor Capital is a seed stage VC firm investing in bio, climate, and health.
Wren Capital
Wren Capital is a new seed capital and early stage investment fund based in London.
Current Employees Featured
Alexey Konov Managing Partner & Founder @ RBV Capital
Managing Partner & Founder
2014-11-01
Robert Karl Partner @ RBV Capital
Partner
Arseniy Shabashvili Associate @ RBV Capital
Associate
2015-12-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-02-11 | Pipeline Therapeutics | RBV Capital investment in Series C - Pipeline Therapeutics | 80 M USD |
| 2020-12-25 | Pandica | RBV Capital investment in Seed Round - Pandica | 105 M RUB |
| 2020-12-23 | Botkin.AI | RBV Capital investment in Series B - Botkin.AI | 160 M RUB |
| 2019-12-18 | Pipeline Therapeutics | RBV Capital investment in Series B - Pipeline Therapeutics | 32 M USD |
| 2019-05-28 | Botkin.AI | RBV Capital investment in Series A - Botkin.AI | 1.5 M USD |
| 2019-01-03 | Immusoft | RBV Capital investment in Series B - Immusoft | 20 M USD |
| 2017-04-19 | Bonti | RBV Capital investment in Series B - Bonti | 11.7 M USD |
| 2015-11-12 | RetroSense Therapeutics | RBV Capital investment in Series B - RetroSense Therapeutics | 6 M USD |
| 2015-04-30 | IAG, Image Analysis Group | RBV Capital investment in Venture Round - IAG, Image Analysis Group | 5.2 M USD |